Riccardo Sartoris

Dr. Riccardo Sartoris


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Radiology
Verified
Journal Article
Closed access
RSRiccardo Sartoris
Riccardo Sartoris
PRPierre-Emmanuel Rautou
Pierre-Emmanuel Rautou
LELaure Elkrief
Laure Elkrief
GPGaia Pollorsi
Gaia Pollorsi
FDFrançois Durand
François Durand
Maxime RonotMaxime Ronot
Maxime Ronot
Purpose To determine whether quantification of liver surface nodularity (LSN) provides an estimate of the presence of clinically significant portal hypertension (CSPH) in patients with cirrhosis. Materials and Methods This retrospective study included a training cohort (n = 189) and separate external validation cohort (n = 78), both composed of patients with cirrhosis who underwent abdominal CT and hepatic venous pressure gradient (HVPG) measurement between 2010 and 2016. The LSN score, liver and spleen volumes, liver-to-spleen volume ratio, platelet count to spleen diameter ratio, Iranmanesh score, aspartate amino transferase-to-platelet ratio index, and Fibrosis-4 index were derived from CT images and serum laboratories. The accuracy of the various tests for predicting CSPH was evaluated with area under the receiver operating characteristic curve (AUROC) and compared by using the DeLong test. Student t test and Pearson correlation coefficient were used. Results One hundred eighty-nine patients were analyzed (119 men [mean age ± standard deviation, 57 years ± 11; range, 29-81 years] and 70 women [mean age, 61 years ± 10; range, 34-83 years]; overall mean age, 58 years ± 10; range, 29-83 years). A total of 102 patients (54%) had CSPH. LSN score correlated with HVPG (r = 0.75; P < .001). Patients with CSPH had a higher LSN score than did those without CSPH (3.2 ± 0.6 vs 2.4 ± 0.3; P < .001). A cutoff value of 2.8 had a positive predictive value of 88% for CSPH; the AUROC of LSN was 0.88 ± 0.03. This was higher than that of other available noninvasive tests (DeLong, all P < .001). In the validation cohort, LSN score of 2.8 had a positive predictive value of 86% for CSPH; the AUROC was 0.87 ± 0.04. Conclusion The CT-based liver surface nodularity score demonstrated high diagnostic performance for detecting clinically significant portal hypertension and outperformed multiple other noninvasive tests. © RSNA, 2018 Online supplemental material is available for this article.

1 February 2015 in European Journal of Radiology
Verified
Journal Article
Closed access
ACAngelo Corazza
Angelo Corazza
Davide OrlandiDavide Orlandi
Davide Orlandi
EFEmanuele Fabbro
Emanuele Fabbro
GFGiulio Ferrero
Giulio Ferrero
CMCarmelo Messina
Carmelo Messina
LSLuca Maria Sconfienza
Luca Maria Sconfienza

23 October 2020 in Cancers
Verified
Journal Article
Open access
PDF file
DTDavid Tobaly
David Tobaly
JSJoão Santinha
João Santinha
RSRiccardo Sartoris
Riccardo Sartoris
MBMarco Dioguardi Burgio
Marco Dioguardi Burgio
CMCelso Matos
Celso Matos
Valérie VilgrainValérie Vilgrain
Valérie Vilgrain
To assess the performance of CT-based radiomics analysis in differentiating benign from malignant intraductal papillary mucinous neoplasms of the pancreas (IPMN), preoperative scans of 408 resected patients with IPMN were retrospectively analyzed. IPMNs were classified as benign (low-grade dysplasia, n = 181), or malignant (high grade, n = 128, and invasive, n = 99). Clinicobiological data were reported. Patients were divided into a training cohort (TC) of 296 patients and an external validation cohort (EVC) of 112 patients. After semi-automatic tumor segmentation, PyRadiomics was used to extract radiomics features. A multivariate model was developed using a logistic regression approach. In the training cohort, 85/107 radiomics features were significantly different between patients with benign and malignant IPMNs. Unsupervised clustering analysis revealed four distinct clusters of patients with similar radiomics features patterns with malignancy as the most significant association. The multivariate model differentiated benign from malignant tumors in TC with an area under the ROC curve (AUC) of 0.84, sensitivity (Se) of 0.82, specificity (Spe) of 0.74, and in EVC with an AUC of 0.71, Se of 0.69, Spe of 0.57. This large study confirms the high diagnostic performance of preoperative CT-based radiomics analysis to differentiate between benign from malignant IPMNs.

1 July 2014 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
GTGiovanni Turtulici
Giovanni Turtulici
Davide OrlandiDavide Orlandi
Davide Orlandi
ACAngelo Corazza
Angelo Corazza
RSRiccardo Sartoris
Riccardo Sartoris
LDLorenzo Egildo Derchi
Lorenzo Egildo Derchi
JBJung Hwan Baek
Jung Hwan Baek

1 February 2024 in Radiology
Verified
Journal Article
Closed access
Roberto CannellaRoberto Cannella
Roberto Cannella
FMFrancesco Matteini
Francesco Matteini
MBMarco Dioguardi Burgio
Marco Dioguardi Burgio
RSRiccardo Sartoris
Riccardo Sartoris
ABAurélie Beaufrère
Aurélie Beaufrère
Maxime RonotMaxime Ronot
Maxime Ronot
Background Both Liver Imaging Reporting and Data System (LI-RADS) and histopathologic features provide prognostic information in patients with hepatocellular carcinoma (HCC), but whether LI-RADS is independently associated with survival is uncertain. Purpose To assess the association of LI-RADS categories and features with survival outcomes in patients with solitary resected HCC. Materials and Methods This retrospective study included patients with solitary resected HCC from three institutions examined with preoperative contrast-enhanced CT and/or MRI between January 2008 and December 2019. Three independent readers evaluated the LI-RADS version 2018 categories and features. Histopathologic features including World Health Organization tumor grade, microvascular and macrovascular invasion, satellite nodules, and tumor capsule were recorded. Overall survival and disease-free survival were assessed with Cox regression models. Marginal effects of nontargetoid features on survival were estimated using propensity score matching. Results A total of 360 patients (median age, 64 years [IQR, 56-70 years]; 280 male patients) were included. At CT and MRI, the LI-RADS LR-M category was associated with increased risk of recurrence (CT: hazard ratio [HR] = 1.83 [95% CI: 1.26, 2.66], P = .001; MRI: HR = 2.22 [95% CI: 1.56, 3.16], P < .001) and death (CT: HR = 2.47 [95% CI: 1.72, 3.55], P < .001; MRI: HR = 1.80 [95% CI: 1.32, 2.46], P < .001) independently of histopathologic features. The presence of at least one nontargetoid feature was associated with an increased risk of recurrence (CT: HR = 1.80 [95% CI: 1.36, 2.38], P < .001; MRI: HR = 1.93 [95% CI: 1.81, 2.06], P < .001) and death (CT: HR = 1.51 [95% CI: 1.10, 2.07], P < .010) independently of histopathologic features. In matched samples, recurrence was associated with the presence of at least one nontargetoid feature at CT (HR = 2.06 [95% CI: 1.15, 3.66]; P = .02) or MRI (HR = 1.79 [95% CI: 1.01, 3.20]; P = .048). Conclusion In patients with solitary resected HCC, LR-M category and nontargetoid features were negatively associated with survival independently of histopathologic characteristics. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Kartalis and Grigoriadis in this issue.

12 January 2017 in Journal of Ultrasound
Verified
Journal Article
Closed access
PDF file
RSRiccardo Sartoris
Riccardo Sartoris
Davide OrlandiDavide Orlandi
Davide Orlandi
ACAngelo Corazza
Angelo Corazza
LSLuca Maria Sconfienza
Luca Maria Sconfienza
AAAlice Arcidiacono
Alice Arcidiacono
ESEnzo Silvestri
Enzo Silvestri